Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. [electronic resource]
Producer: 20130520Description: 410-5 p. digitalISSN:- 1572-0241
- Administration, Rectal
- Adult
- Aged
- Cholangiopancreatography, Endoscopic Retrograde -- adverse effects
- Cost-Benefit Analysis
- Female
- Humans
- Indomethacin -- administration & dosage
- Male
- Middle Aged
- Pancreatitis -- economics
- Prospective Studies
- Retrospective Studies
- Risk Factors
- Stents -- economics
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.